LONZA Trademark
Trademark Overview
On Thursday, October 12, 2023, a trademark application was filed for LONZA with the United States Patent and Trademark Office. The USPTO has given the LONZA trademark a serial number of 79389966. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 3, 2024. This trademark is owned by Lonza Ltd.. The LONZA trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:
Biological materials for medical and pharmaceutical use, namely, genetically modified cells, genetic material and vectors, namely,
cosmids, plasmids, viral material, or chromosomes for production of human, animal and synthetic proteins for medical, clinical and
commercial use; human or animal blood, tissue, blood cells and stem-cells for medical, clinical and commercial use;
biopharmaceuticals, namely, antibodies and proteins for medical and pharmaceutical use; bioscience products, namely, primary
cells, cell cultures and transfection products in the nature of human and animal cells for medical, clinical and commercial use in
human and animal therapies; dietary and nutritional supplements; nutritional ingredients in the nature of nutritional supplements
as components of dietary regimes and nutritional supplements for medical use in bulk, in the form of tablets, capsules, gel,
powder, and liquid or as food additives
Biological materials, namely, genetically modified cells for scientific and research use; biological tissue in the nature of genetic material and vectors, namely, cosmids, plasmids, viral material, or chromosomes for production of human, animal and synthetic proteins for scientific and pharmaceutical research; biological tissue, namely, human or animal blood, tissue and stem cells for use in scientific and pharmaceutical research; bioconjugates for scientific and pharmaceutical research; bioscience products, being biological tissue in the nature of primary cells, cell cultures and transfection compounds for life-science research; nutritional chemical compounds in bulk powder, tablet, capsule, gel, powder, and liquid form used in the manufacture of dietary and nutritional supplements or food additives; biological preparations, namely, genetically modified cells, genetic material and vectors in the nature of cosmids, plasmids, viral material, or chromosomes for the production of human, a...
General Information
| Serial Number | 79389966 |
| Word Mark | LONZA |
| Filing Date | Thursday, October 12, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, December 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, December 3, 2024 |
Trademark Statements
| Goods and Services | Biological materials for medical and pharmaceutical use, namely, genetically modified cells, genetic material and vectors, namely,
cosmids, plasmids, viral material, or chromosomes for production of human, animal and synthetic proteins for medical, clinical and
commercial use; human or animal blood, tissue, blood cells and stem-cells for medical, clinical and commercial use;
biopharmaceuticals, namely, antibodies and proteins for medical and pharmaceutical use; bioscience products, namely, primary
cells, cell cultures and transfection products in the nature of human and animal cells for medical, clinical and commercial use in
human and animal therapies; dietary and nutritional supplements; nutritional ingredients in the nature of nutritional supplements
as components of dietary regimes and nutritional supplements for medical use in bulk, in the form of tablets, capsules, gel,
powder, and liquid or as food additives |
| Goods and Services | Biological materials, namely, genetically modified cells for scientific and research use; biological tissue in the nature of genetic material and vectors, namely, cosmids, plasmids, viral material, or chromosomes for production of human, animal and synthetic proteins for scientific and pharmaceutical research; biological tissue, namely, human or animal blood, tissue and stem cells for use in scientific and pharmaceutical research; bioconjugates for scientific and pharmaceutical research; bioscience products, being biological tissue in the nature of primary cells, cell cultures and transfection compounds for life-science research; nutritional chemical compounds in bulk powder, tablet, capsule, gel, powder, and liquid form used in the manufacture of dietary and nutritional supplements or food additives; biological preparations, namely, genetically modified cells, genetic material and vectors in the nature of cosmids, plasmids, viral material, or chromosomes for the production of human, animal and synthetic proteins for commercial use, other than for medical or veterinary use; biological preparations for use in industry and science, namely, blood, tissue, blood cells and human or animal stem cells, for commercial use; biological preparations for use in industry and science, namely, bioconjugates for drug development; biological preparations for use in industry and science, namely, primary cells, cell cultures and transfection animal tissue for commercial use in human and animal therapies; biopharmaceutical chemicals, namely, monoclonal antibodies and proteins for scientific and pharmaceutical research |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 23, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 23, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Lonza Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Party Name | Lonza Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Thursday, February 22, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, February 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 23, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, February 27, 2024 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 18, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 19, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, April 6, 2024 | REFUSAL PROCESSED BY MPU |
| Saturday, April 6, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, April 15, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 15, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 15, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 1, 2024 | REFUSAL PROCESSED BY IB |
| Monday, June 17, 2024 | ASSIGNED TO LIE |
| Friday, August 16, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, August 16, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, August 16, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 4, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, September 4, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 4, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, September 12, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, September 12, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, September 12, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Saturday, November 9, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 27, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 3, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 3, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
